Investment
Features
FeesSafety
Academy
More
Pluang+

Compare ADMA Biologics Inc (ADMA) vs Impinj Inc (PI) Price & Performance

ADMA Biologics IncTrade
Impinj IncTrade

Price performance (Past 24H)

Key statistics

ADMA Biologics Inc vs Impinj Inc — how do they compare? ADMA Biologics Inc trades at $9.88 (market cap $2.22B), while Impinj Inc trades at $177.46 (market cap $5.32B). The key difference: Impinj Inc is far larger — about 2.4× ADMA Biologics Inc's market cap, and Impinj Inc is trading nearer its 52-week high, ADMA Biologics Inc nearer its low. Which is the better fit depends on your goals.

ADMAPI
Market Cap
$2.22B$5.32B
Sector
HealthTechnology
52-Week High
$20.38$241.91
52-Week Low
$7.60$91.34
Enterprise Value
$2.29B$5.45B

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About ADMA Biologics Inc

ADMA Biologics is a biopharmaceutical company specializing in plasma-derived therapies for immunodeficient patients. Key products like ASCENIV and BIVIGAM treat primary humoral immunodeficiency and help prevent infectious diseases.

Read more on ADMA

About Impinj Inc

Impinj, Inc. is a leading provider of RAIN RFID (radio-frequency identification) solutions. The company's platform includes endpoints (tag chips), connectivity devices (readers and gateways), and software, enabling businesses to wirelessly identify, locate, and authenticate everyday items. Impinj's technology is crucial for applications in retail, supply chain management, healthcare, and logistics, helping businesses to automate inventory, track assets, and improve operational efficiency.

Read more on PI